Gladstone Institutional Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
669
+91
| +16% | +$35.4K | 0.01% | 638 |
|
|
2025
Q1 | $252K | Buy |
+578
| New | +$252K | 0.01% | 633 |
|
|
2024
Q4 | – | Sell |
-564
| Closed | -$293K | – | 707 |
|
|
2024
Q3 | $293K | Sell |
564
-43
| -7% | -$22.3K | 0.01% | 578 |
|
|
2024
Q2 | $329K | Sell |
607
-416
| -41% | -$226K | 0.02% | 516 |
|
|
2024
Q1 | $531K | Sell |
1,023
-149
| -13% | -$77.3K | 0.03% | 401 |
|
|
2023
Q4 | $553K | Buy |
1,172
+42
| +4% | +$19.8K | 0.03% | 398 |
|
|
2023
Q3 | $492K | Buy |
1,130
+33
| +3% | +$14.4K | 0.03% | 389 |
|
|
2023
Q2 | $487K | Buy |
1,097
+150
| +16% | +$66.6K | 0.03% | 401 |
|
|
2023
Q1 | $435K | Buy |
947
+48
| +5% | +$22.1K | 0.03% | 438 |
|
|
2022
Q4 | $461K | Sell |
899
-114
| -11% | -$58.5K | 0.03% | 418 |
|
|
2022
Q3 | $460K | Buy |
1,013
+47
| +5% | +$21.3K | 0.04% | 413 |
|
|
2022
Q2 | $466K | Sell |
966
-149
| -13% | -$71.9K | 0.04% | 425 |
|
|
2022
Q1 | $548K | Sell |
1,115
-50
| -4% | -$24.6K | 0.04% | 413 |
|
|
2021
Q4 | $540K | Buy |
1,165
+43
| +4% | +$19.9K | 0.04% | 367 |
|
|
2021
Q3 | $418K | Buy |
1,122
+51
| +5% | +$19K | 0.04% | 367 |
|
|
2021
Q2 | $409K | Buy |
1,071
+59
| +6% | +$22.5K | 0.05% | 330 |
|
|
2021
Q1 | $363K | Buy |
+1,012
| New | +$363K | 0.06% | 289 |
|